Stock Events

Stock Events

Merus N.V 

€79
35
-€0.5-0.63% Monday 14:29

Statistics

Day High
80.5
Day Low
80
52W High
82
52W Low
29.4
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

4MarExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-2.23
-1.65
-1.06
-0.48
Expected EPS
-1.110569
Actual EPS
N/A

Financials

-593.37%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
68.46MRevenue
-406.22MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2GH.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap79.46B
Regeneron Pharmaceuticals, Inc. competes in the biotechnology industry focusing on innovative biologic medicines, similar to Merus' focus on cancer and antibody therapies.
AMGEN
AMGN
Mkt Cap185.74B
Amgen Inc. is a biotech firm that develops therapeutic products in areas overlapping with Merus, such as oncology.
Bristol-Myers Squibb
BMY
Mkt Cap119.87B
Bristol-Myers Squibb Company operates in the global biopharmaceutical industry, directly competing with Merus in the development of cancer treatments.
Gilead Sciences
GILD
Mkt Cap161.85B
Gilead Sciences, Inc. is involved in the discovery, development, and commercialization of innovative therapeutics in areas including oncology, where Merus is also active.
Merck
MRK
Mkt Cap276.38B
Merck & Co., Inc. is a global healthcare company that develops cancer therapies, competing with Merus in the oncology market.
Pfizer
PFE
Mkt Cap153.59B
Pfizer Inc. is a research-based biopharmaceutical company with a broad range of products including oncology, directly competing with Merus.
Novartis
NVS
Mkt Cap280.79B
Novartis AG focuses on patented medicines, including those for cancer, making it a direct competitor to Merus in the oncology field.
Astrazeneca
AZN
Mkt Cap294.17B
AstraZeneca PLC is a global, science-led biopharmaceutical business that operates in the same therapeutic areas as Merus, including oncology.

About

Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes BIZENGRI for the treatment of patients with pancreatic adenocarcinoma or non-small cell lung cancer (NSCLC) and non Neuregulin 1. The company is also developing MCLA-158 for the treatment of solid tumors; MCLA-129 for the treatment of patients with lungs and other solid tumors; ONO-4685 to treat relapsed/refractory T cell lymphoma; and INCA33890 for advanced solid tumors. In addition, it has collaboration agreement with Eli Lilly and Company, Ono Pharmaceutical Co., Ltd., and Betta Pharmaceuticals Co. Ltd. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.
Show more...
CEO
Dr. Sven Ante Lundberg M.D.
Employees
260
Country
Netherlands
ISIN
NL0011606264
WKN
000A2AKFX

Listings

0 Comments

Share your thoughts

FAQ

What is Merus N.V stock price today?▼
The current price of 2GH.F is €79 EUR — it has decreased by -0.63% in the past 24 hours. Watch Merus N.V stock price performance more closely on the chart.
What is Merus N.V stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Merus N.V stocks are traded under the ticker 2GH.F.
Is Merus N.V stock price growing?▼
2GH.F stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Merus N.V has showed a +142.33% increase.
What is Merus N.V revenue for the last year?▼
Merus N.V revenue for the last year amounts to 68.46M EUR.
What is Merus N.V net income for the last year?▼
2GH.F net income for the last year is -406.22M EUR.
How many employees does Merus N.V have?▼
As of April 29, 2026, the company has 260 employees.
In which sector is Merus N.V located?▼
Merus N.V operates in the Health & Wellness sector.
When did Merus N.V complete a stock split?▼
Merus N.V has not had any recent stock splits.
Where is Merus N.V headquartered?▼
Merus N.V is headquartered in Utrecht, Netherlands.